Carregant...
Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
BACKGROUND: To evaluate therapeutic outcomes of interferon alpha-2a (IFNα2a) treatment in patients with Behcet’s disease who were refractory to immunosuppressive agents. METHODS: This retrospective case series reviewed the medical records of 5 patients with refractory Behcet uveitis from January 201...
Guardat en:
| Publicat a: | BMC Ophthalmol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5819294/ https://ncbi.nlm.nih.gov/pubmed/29463220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-018-0719-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|